After a pilot evaluation of the ShangRing device in 2011, Kenya conducted active surveillance for adverse events associated with its use from 2016-2018 to further assess the safety and uptake of ShangRing-assisted male circumcision and to identify any operational bottlenecks to its widespread use based on data from a larger pool of procedures in routine health care settings. The results are reported in this article in PLoS One.